Further delineation of these pathways in MEFs and other cell types will be important for defining a role for β-AR agonists/antagonists in cancer treatment and will be useful to understanding how states of chronic catecholamine excess (e.g., heart failure) can lead to proliferation or apoptosis of different cell types. The gene discussed is ADRB2; the disease is heart failure.